BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7363532)

  • 1. Absorption of ocular timolol.
    Alvan G; Calissendorff B; Seideman P; Widmark K; Widmark G
    Clin Pharmacokinet; 1980; 5(1):95-100. PubMed ID: 7363532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timolol: a review of its therapeutic efficacy in the topical treatment of glaucoma.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1979 Jan; 17(1):38-55. PubMed ID: 369807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics and kinetics of ophthalmic timolol.
    Affrime MB; Lowenthal DT; Tobert JA; Shirk J; Eidelson B; Cook T; Onesti G
    Clin Pharmacol Ther; 1980 Apr; 27(4):471-7. PubMed ID: 7357805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Are 0.1% timolol-maleate eyedrops suitable for treating chronic glaucoma? (author's transl)].
    Dausch D; Schad K
    Klin Monbl Augenheilkd; 1982 Feb; 180(2):141-5. PubMed ID: 7087342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experiences with timolol eye drops].
    Ober M; Meythaler H; Porkert K
    Ophthalmologica; 1979; 178(4):204-9. PubMed ID: 481866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of timolol into the rabbit eye. Measurements after ocular instillation and intravenous injection.
    Schmitt CJ; Lotti VJ; LeDouarec JC
    Arch Ophthalmol; 1980 Mar; 98(3):547-51. PubMed ID: 7362514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with timolol ophthalmic solution in open-angle glaucoma.
    Demailly P; Arrata M
    Ophthalmologica; 1980; 181(3-4):221-7. PubMed ID: 7231889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timolol, dose response and duration of action.
    Zimmerman TJ; Kaufman HE
    Arch Ophthalmol; 1977 Apr; 95(4):605-7. PubMed ID: 322649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on drug therapy: II. Timolol maleate ophthalmic solution.
    Secter RA; Elenbaas JK; Hamburger S
    J Am Med Womens Assoc (1972); 1980 Feb; 35(2):31-3. PubMed ID: 6246154
    [No Abstract]   [Full Text] [Related]  

  • 10. Diacetyl derivative of nadolol. I. Ocular pharmacology and short-term ocular hypotensive effect in glaucomatous eyes.
    Duzman E; Chen CC; Anderson J; Blumenthal M; Twizer H
    Arch Ophthalmol; 1982 Dec; 100(12):1916-9. PubMed ID: 6756362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans.
    Urtti A; Rouhiainen H; Kaila T; Saano V
    Pharm Res; 1994 Sep; 11(9):1278-82. PubMed ID: 7816756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma timolol in glaucoma patients.
    Passo MS; Palmer EA; Van Buskirk EM
    Ophthalmology; 1984 Nov; 91(11):1361-3. PubMed ID: 6514303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential side effects of timolol therapy in the treatment of glaucoma.
    Zimmerman TJ; Leader BJ; Golob DS
    Ann Ophthalmol; 1981 Jun; 13(6):683-9. PubMed ID: 7020551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical timolol and the nursing mother.
    Lustgarten JS; Podos SM
    Arch Ophthalmol; 1983 Sep; 101(9):1381-2. PubMed ID: 6615302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of timolol eye drops into human aqueous humour.
    Phillips CI; Bartholomew RS; Kazi G; Schmitt CJ; Vogel R
    Br J Ophthalmol; 1981 Sep; 65(9):593-5. PubMed ID: 7295625
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of timolol eye drops on the intraocular pressure in simple glaucoma (author's transl)].
    Krieglstein GK
    Klin Monbl Augenheilkd; 1978 May; 172(5):677-85. PubMed ID: 672089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination.
    Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):581-7. PubMed ID: 22011049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels and systemic safety of 0.1% unpreserved timolol maleate gel, 0.5% timolol aqueous solution and 0.5% timolol maleate gel.
    Bonnin N; Nezzar H; Dubray C; Renault D; Olmiere C; Chiambaretta F
    J Fr Ophtalmol; 2012 Jan; 35(1):9-16. PubMed ID: 21992993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta-receptor blocking agents and glaucoma; timolol in eye drops].
    Ros FE; Dake CL; Innemee HC; van Zwieten PA
    Ned Tijdschr Geneeskd; 1981 Mar; 125(11):422-5. PubMed ID: 7219582
    [No Abstract]   [Full Text] [Related]  

  • 20. Timolol eye drops: bradycardia or tachycardia?
    Ros FE; Dake CL
    Doc Ophthalmol; 1980 Apr; 48(2):283-9. PubMed ID: 7398530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.